Compare $AZTR vs $SKYE | Chartloom

Compare

$AZTR vs $SKYE

Azitra Inc · Skye Bioscience Inc

AZTR

Azitra Inc

SKYE

Skye Bioscience Inc

Compare $AZTR vs $SKYE

Comparing Azitra Inc and Skye Bioscience Inc

AZTRAzitra Inc

SKYESkye Bioscience Inc

AZTRAzitra Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-53.4%

52W performance

-82.4%

FCF yield

-531.3%

SKYESkye Bioscience Inc

Market cap

$59M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.9%

52W performance

-87.7%

FCF yield

-65.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AZTR

SKYE

Detailed metrics comparison

AZTR

Azitra Inc

SKYE

Skye Bioscience Inc

Market Cap

AZTR$2M

SKYE$59M

Enterprise Value

AZTR$-5M

SKYE$51M

Price

AZTR$0.13

SKYE$1.69

P/E Ratio

AZTRN/A

SKYEN/A

P/S Ratio

AZTR19.60x

SKYE26.57x

EV/Sales

AZTR3.12x

SKYE0.00x

EV/EBITDA

AZTR0.00x

SKYE0.00x

P/B Ratio

AZTR1.09x

SKYE0.83x

P/FCF Ratio

AZTRN/A

SKYEN/A

EV/FCF

AZTR0.41x

SKYE-1.31x

PEG Ratio

AZTRN/A

SKYEN/A

Forward P/E (NTM)

AZTRN/A

SKYEN/A

Forward P/S (NTM)

AZTRN/A

SKYEN/A

Revenue (TTM)

AZTR$0

SKYE$0

Revenue Growth (YoY)

AZTRN/A

SKYEN/A

Forward Rev Growth

AZTR73.2%

SKYE307.4%

Gross Margin (TTM)

AZTR0.0%

SKYE39.3%

Operating Margin (TTM)

AZTR0.0%

SKYE0.0%

EBITDA Margin (TTM)

AZTR0.0%

SKYE0.0%

Net Margin (TTM)

AZTR0.0%

SKYE0.0%

FCF Margin (TTM)

AZTRN/A

SKYEN/A

Net Income (TTM)

AZTR$-5M

SKYE$-50M

FCF (TTM)

AZTR$-11M

SKYE$-39M

EPS (TTM)

AZTR$0.00

SKYE-$10.18

ROE (TTM)

AZTR-28475.0%

SKYE-21727.0%

ROA (TTM)

AZTR-17815.0%

SKYE-20179.0%

ROIC (TTM)

AZTR-26746.0%

SKYE-21675.0%

Cash

AZTR$7M

SKYE$9M

Debt

AZTR$2K

SKYE$143K

Net Cash/Debt

AZTR$7M

SKYE$8M

Current Ratio (TTM)

AZTR4.86x

SKYE0.95x

Quick Ratio (TTM)

AZTR4.49x

SKYE0.91x

Debt/Equity (TTM)

AZTR0.00x

SKYE0.03x

Debt/Assets (TTM)

AZTR0.0%

SKYE0.0%

Interest Coverage (TTM)

AZTRN/A

SKYEN/A

Net Debt/EBITDA (TTM)

AZTR0.00x

SKYE0.00x

Beta

AZTR-1.00

SKYE3.13

52W Performance

AZTR-82.4%

SKYE-87.7%

YTD Performance

AZTR-53.4%

SKYE-75.9%

% from 52W High

AZTR-88.1%

SKYE-88.0%

% from 52W Low

AZTR29.9%

SKYE12.7%

Asset Turnover (TTM)

AZTR0.07x

SKYE1.93x

FCF Yield (TTM)

AZTR-531.3%

SKYE-65.4%

Earnings Yield (TTM)

AZTR-237.7%

SKYE-85.0%

Dividend Yield (TTM)

AZTRN/A

SKYEN/A

Rule of 40

AZTR0.0

SKYE0.0

EV/GP/RG

AZTRN/A

SKYEN/A

Ticker research

View AZTR research View SKYE research

Metric	AZTR Azitra Inc	SKYE Skye Bioscience Inc
Market & Valuation
Market Cap	$2M	$59M
Enterprise Value	$-5M	$51M
Price	$0.13	$1.69
P/E Ratio	N/A	N/A
P/S Ratio	19.60x	26.57x
EV/Sales	3.12x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	0.83x
P/FCF Ratio	N/A	N/A
EV/FCF	0.41x	-1.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	73.2%	307.4%
Profitability
Gross Margin (TTM)	0.0%	39.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-5M	$-50M
FCF (TTM)	$-11M	$-39M
EPS (TTM)	$0.00	-$10.18
ROE (TTM)	-28475.0%	-21727.0%
ROA (TTM)	-17815.0%	-20179.0%
ROIC (TTM)	-26746.0%	-21675.0%
Financial Health
Cash	$7M	$9M
Debt	$2K	$143K
Net Cash/Debt	$7M	$8M
Current Ratio (TTM)	4.86x	0.95x
Quick Ratio (TTM)	4.49x	0.91x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.00	3.13
52W Performance	-82.4%	-87.7%
YTD Performance	-53.4%	-75.9%
% from 52W High	-88.1%	-88.0%
% from 52W Low	29.9%	12.7%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	1.93x
FCF Yield (TTM)	-531.3%	-65.4%
Earnings Yield (TTM)	-237.7%	-85.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AZTR research	View SKYE research

Valuation

P/S Ratio

AZTR

19.60x

SKYE

26.57x

EV/FCF

SKYE

-1.31x

AZTR

0.41x

Growth & revenue

Forward Revenue Growth

SKYE

307.4%

AZTR

73.2%

Profitability & performance

Gross Margin

SKYE

39.3%

AZTR

0.0%

ROE

SKYE

-21727.0%

AZTR

-28475.0%

FCF Yield %

SKYE

-65.4%

AZTR

-531.3%

52-Week Performance

AZTR

-82.4%

SKYE

-87.7%

Detailed metrics comparison

AZTR

Azitra Inc

SKYE

Skye Bioscience Inc

Market Cap

AZTR$2M

SKYE$59M

Enterprise Value

AZTR$-5M

SKYE$51M

Price

AZTR$0.13

SKYE$1.69

P/E Ratio

AZTRN/A

SKYEN/A

P/S Ratio

AZTR19.60x

SKYE26.57x

EV/Sales

AZTR3.12x

SKYE0.00x

EV/EBITDA

AZTR0.00x

SKYE0.00x

P/B Ratio

AZTR1.09x

SKYE0.83x

P/FCF Ratio

AZTRN/A

SKYEN/A

EV/FCF

AZTR0.41x

SKYE-1.31x

PEG Ratio

AZTRN/A

SKYEN/A

Forward P/E (NTM)

AZTRN/A

SKYEN/A

Forward P/S (NTM)

AZTRN/A

SKYEN/A

Revenue (TTM)

AZTR$0

SKYE$0

Revenue Growth (YoY)

AZTRN/A

SKYEN/A

Forward Rev Growth

AZTR73.2%

SKYE307.4%

Gross Margin (TTM)

AZTR0.0%

SKYE39.3%

Operating Margin (TTM)

AZTR0.0%

SKYE0.0%

EBITDA Margin (TTM)

AZTR0.0%

SKYE0.0%

Net Margin (TTM)

AZTR0.0%

SKYE0.0%

FCF Margin (TTM)

AZTRN/A

SKYEN/A

Net Income (TTM)

AZTR$-5M

SKYE$-50M

FCF (TTM)

AZTR$-11M

SKYE$-39M

EPS (TTM)

AZTR$0.00

SKYE-$10.18

ROE (TTM)

AZTR-28475.0%

SKYE-21727.0%

ROA (TTM)

AZTR-17815.0%

SKYE-20179.0%

ROIC (TTM)

AZTR-26746.0%

SKYE-21675.0%

Cash

AZTR$7M

SKYE$9M

Debt

AZTR$2K

SKYE$143K

Net Cash/Debt

AZTR$7M

SKYE$8M

Current Ratio (TTM)

AZTR4.86x

SKYE0.95x

Quick Ratio (TTM)

AZTR4.49x

SKYE0.91x

Debt/Equity (TTM)

AZTR0.00x

SKYE0.03x

Debt/Assets (TTM)

AZTR0.0%

SKYE0.0%

Interest Coverage (TTM)

AZTRN/A

SKYEN/A

Net Debt/EBITDA (TTM)

AZTR0.00x

SKYE0.00x

Beta

AZTR-1.00

SKYE3.13

52W Performance

AZTR-82.4%

SKYE-87.7%

YTD Performance

AZTR-53.4%

SKYE-75.9%

% from 52W High

AZTR-88.1%

SKYE-88.0%

% from 52W Low

AZTR29.9%

SKYE12.7%

Asset Turnover (TTM)

AZTR0.07x

SKYE1.93x

FCF Yield (TTM)

AZTR-531.3%

SKYE-65.4%

Earnings Yield (TTM)

AZTR-237.7%

SKYE-85.0%

Dividend Yield (TTM)

AZTRN/A

SKYEN/A

Rule of 40

AZTR0.0

SKYE0.0

EV/GP/RG

AZTRN/A

SKYEN/A

Ticker research

View AZTR research View SKYE research

Metric	AZTR Azitra Inc	SKYE Skye Bioscience Inc
Market & Valuation
Market Cap	$2M	$59M
Enterprise Value	$-5M	$51M
Price	$0.13	$1.69
P/E Ratio	N/A	N/A
P/S Ratio	19.60x	26.57x
EV/Sales	3.12x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	0.83x
P/FCF Ratio	N/A	N/A
EV/FCF	0.41x	-1.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	73.2%	307.4%
Profitability
Gross Margin (TTM)	0.0%	39.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-5M	$-50M
FCF (TTM)	$-11M	$-39M
EPS (TTM)	$0.00	-$10.18
ROE (TTM)	-28475.0%	-21727.0%
ROA (TTM)	-17815.0%	-20179.0%
ROIC (TTM)	-26746.0%	-21675.0%
Financial Health
Cash	$7M	$9M
Debt	$2K	$143K
Net Cash/Debt	$7M	$8M
Current Ratio (TTM)	4.86x	0.95x
Quick Ratio (TTM)	4.49x	0.91x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.00	3.13
52W Performance	-82.4%	-87.7%
YTD Performance	-53.4%	-75.9%
% from 52W High	-88.1%	-88.0%
% from 52W Low	29.9%	12.7%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	1.93x
FCF Yield (TTM)	-531.3%	-65.4%
Earnings Yield (TTM)	-237.7%	-85.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AZTR research	View SKYE research